Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zumutor Biologics Inc.

Clinical trials sponsored by Zumutor Biologics Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibody combo takes on Hard-to-Treat cancers Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New antibody combo takes on Hard-to-Treat cancers

Disease control Recruiting now

This early-phase trial is testing a new antibody drug called ZM008, first by itself and then together with another drug (toripalimab), in people with advanced solid tumors like lung, head and neck, and pancreatic cancers. The study aims to find a safe dose and see if the combinat…

Phase 1 • Sponsor: Zumutor Biologics Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC